BRPI0617498A2 - processo para a produÇço de l-serina, seqÜÊncia de gene, vetores e microorganismos - Google Patents
processo para a produÇço de l-serina, seqÜÊncia de gene, vetores e microorganismos Download PDFInfo
- Publication number
- BRPI0617498A2 BRPI0617498A2 BRPI0617498-1A BRPI0617498A BRPI0617498A2 BR PI0617498 A2 BRPI0617498 A2 BR PI0617498A2 BR PI0617498 A BRPI0617498 A BR PI0617498A BR PI0617498 A2 BRPI0617498 A2 BR PI0617498A2
- Authority
- BR
- Brazil
- Prior art keywords
- process according
- gene
- seq
- folic acid
- corinebacterium
- Prior art date
Links
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 title claims abstract description 74
- 108090000623 proteins and genes Proteins 0.000 title claims abstract description 67
- 238000000034 method Methods 0.000 title claims abstract description 56
- 230000008569 process Effects 0.000 title claims abstract description 44
- 239000013598 vector Substances 0.000 title claims abstract description 33
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 22
- 244000005700 microbiome Species 0.000 title claims abstract description 22
- 230000015572 biosynthetic process Effects 0.000 claims abstract description 47
- 229960001153 serine Drugs 0.000 claims abstract description 36
- 108090000790 Enzymes Proteins 0.000 claims abstract description 23
- 102000004190 Enzymes Human genes 0.000 claims abstract description 23
- 230000000694 effects Effects 0.000 claims abstract description 18
- 229940024606 amino acid Drugs 0.000 claims abstract description 12
- 150000001413 amino acids Chemical class 0.000 claims abstract description 10
- 239000002253 acid Substances 0.000 claims abstract 3
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 claims description 93
- 235000019152 folic acid Nutrition 0.000 claims description 47
- 239000011724 folic acid Substances 0.000 claims description 47
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 claims description 46
- 229960000304 folic acid Drugs 0.000 claims description 46
- 238000003786 synthesis reaction Methods 0.000 claims description 29
- 238000012217 deletion Methods 0.000 claims description 26
- 230000037430 deletion Effects 0.000 claims description 26
- 239000013612 plasmid Substances 0.000 claims description 14
- 230000004048 modification Effects 0.000 claims description 13
- 238000012986 modification Methods 0.000 claims description 13
- 230000035772 mutation Effects 0.000 claims description 13
- 241000894006 Bacteria Species 0.000 claims description 11
- 235000001014 amino acid Nutrition 0.000 claims description 11
- 230000014509 gene expression Effects 0.000 claims description 10
- 230000009467 reduction Effects 0.000 claims description 9
- 230000003313 weakening effect Effects 0.000 claims description 8
- 241000186146 Brevibacterium Species 0.000 claims description 6
- 108010038555 Phosphoglycerate dehydrogenase Proteins 0.000 claims description 5
- BZQFBWGGLXLEPQ-REOHCLBHSA-N phosphoserine Chemical compound OC(=O)[C@@H](N)COP(O)(O)=O BZQFBWGGLXLEPQ-REOHCLBHSA-N 0.000 claims description 4
- 101150002295 serA gene Proteins 0.000 claims description 4
- 102000036509 GTP Cyclohydrolase Human genes 0.000 claims description 3
- 108010023555 GTP Cyclohydrolase Proteins 0.000 claims description 3
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 claims description 3
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims description 3
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 claims description 3
- 239000012190 activator Substances 0.000 claims description 3
- 230000003197 catalytic effect Effects 0.000 claims description 3
- 235000018417 cysteine Nutrition 0.000 claims description 3
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 claims description 3
- 230000037431 insertion Effects 0.000 claims description 3
- 238000003780 insertion Methods 0.000 claims description 3
- 101150015622 pyk gene Proteins 0.000 claims description 3
- 101150060936 serB gene Proteins 0.000 claims description 3
- 101150003830 serC gene Proteins 0.000 claims description 3
- 108700028369 Alleles Proteins 0.000 claims description 2
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 claims description 2
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 claims description 2
- 102000045595 Phosphoprotein Phosphatases Human genes 0.000 claims description 2
- 108700019535 Phosphoprotein Phosphatases Proteins 0.000 claims description 2
- 102000003929 Transaminases Human genes 0.000 claims description 2
- 108090000340 Transaminases Proteins 0.000 claims description 2
- 101150097303 glyA gene Proteins 0.000 claims description 2
- 101150117293 metC gene Proteins 0.000 claims description 2
- 229930182817 methionine Natural products 0.000 claims description 2
- 230000017854 proteolysis Effects 0.000 claims description 2
- 101150100082 sdaA gene Proteins 0.000 claims description 2
- 101150081616 trpB gene Proteins 0.000 claims description 2
- 108091028043 Nucleic acid sequence Proteins 0.000 claims 4
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims 3
- 108020005350 Initiator Codon Proteins 0.000 claims 1
- BMQYVXCPAOLZOK-UHFFFAOYSA-N Trihydroxypropylpterisin Natural products OCC(O)C(O)C1=CN=C2NC(N)=NC(=O)C2=N1 BMQYVXCPAOLZOK-UHFFFAOYSA-N 0.000 claims 1
- 230000003247 decreasing effect Effects 0.000 claims 1
- 238000010830 demodification reaction Methods 0.000 claims 1
- 210000002758 humerus Anatomy 0.000 claims 1
- 101150095957 ilvA gene Proteins 0.000 claims 1
- BMQYVXCPAOLZOK-XINAWCOVSA-N neopterin Chemical compound OC[C@@H](O)[C@@H](O)C1=CN=C2NC(N)=NC(=O)C2=N1 BMQYVXCPAOLZOK-XINAWCOVSA-N 0.000 claims 1
- MTCFGRXMJLQNBG-TZDVBLAASA-N (2S)-2-amino-3-hydroxy(314C)propanoic acid Chemical compound N[C@@H]([14CH2]O)C(=O)O MTCFGRXMJLQNBG-TZDVBLAASA-N 0.000 abstract 1
- 241000186226 Corynebacterium glutamicum Species 0.000 description 19
- 108020004414 DNA Proteins 0.000 description 14
- 238000006243 chemical reaction Methods 0.000 description 13
- 239000012634 fragment Substances 0.000 description 13
- 239000002609 medium Substances 0.000 description 9
- 229930006000 Sucrose Natural products 0.000 description 8
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 8
- 229930027917 kanamycin Natural products 0.000 description 8
- 229960000318 kanamycin Drugs 0.000 description 8
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 8
- 229930182823 kanamycin A Natural products 0.000 description 8
- 239000005720 sucrose Substances 0.000 description 8
- 238000010276 construction Methods 0.000 description 7
- 238000013519 translation Methods 0.000 description 7
- 238000000855 fermentation Methods 0.000 description 6
- 230000004151 fermentation Effects 0.000 description 6
- 101150070572 pabC gene Proteins 0.000 description 6
- 238000010561 standard procedure Methods 0.000 description 5
- 241001485655 Corynebacterium glutamicum ATCC 13032 Species 0.000 description 4
- 150000008575 L-amino acids Chemical class 0.000 description 4
- 238000009825 accumulation Methods 0.000 description 4
- 239000011543 agarose gel Substances 0.000 description 4
- 230000033228 biological regulation Effects 0.000 description 4
- 239000013611 chromosomal DNA Substances 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 4
- 230000035945 sensitivity Effects 0.000 description 4
- 241000588724 Escherichia coli Species 0.000 description 3
- 206010016880 Folate deficiency Diseases 0.000 description 3
- 208000010188 Folic Acid Deficiency Diseases 0.000 description 3
- 238000012408 PCR amplification Methods 0.000 description 3
- 239000007621 bhi medium Substances 0.000 description 3
- 230000002759 chromosomal effect Effects 0.000 description 3
- 210000000349 chromosome Anatomy 0.000 description 3
- 230000000295 complement effect Effects 0.000 description 3
- 230000009849 deactivation Effects 0.000 description 3
- 238000004520 electroporation Methods 0.000 description 3
- 229940023064 escherichia coli Drugs 0.000 description 3
- 239000000499 gel Substances 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 238000002703 mutagenesis Methods 0.000 description 3
- 231100000350 mutagenesis Toxicity 0.000 description 3
- 101150016334 pabAB gene Proteins 0.000 description 3
- 238000012163 sequencing technique Methods 0.000 description 3
- 108091034117 Oligonucleotide Proteins 0.000 description 2
- 238000010222 PCR analysis Methods 0.000 description 2
- 239000004098 Tetracycline Substances 0.000 description 2
- -1 aromatic amino acid Chemical class 0.000 description 2
- 230000006696 biosynthetic metabolic pathway Effects 0.000 description 2
- 230000015556 catabolic process Effects 0.000 description 2
- ZPUCINDJVBIVPJ-LJISPDSOSA-N cocaine Chemical compound O([C@H]1C[C@@H]2CC[C@@H](N2C)[C@H]1C(=O)OC)C(=O)C1=CC=CC=C1 ZPUCINDJVBIVPJ-LJISPDSOSA-N 0.000 description 2
- 230000002950 deficient Effects 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 230000006801 homologous recombination Effects 0.000 description 2
- 238000002744 homologous recombination Methods 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 239000002773 nucleotide Substances 0.000 description 2
- 125000003729 nucleotide group Chemical group 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 229960002180 tetracycline Drugs 0.000 description 2
- 229930101283 tetracycline Natural products 0.000 description 2
- 235000019364 tetracycline Nutrition 0.000 description 2
- 150000003522 tetracyclines Chemical class 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- 239000001226 triphosphate Substances 0.000 description 2
- 235000011178 triphosphate Nutrition 0.000 description 2
- 125000002264 triphosphate group Chemical class [H]OP(=O)(O[H])OP(=O)(O[H])OP(=O)(O[H])O* 0.000 description 2
- 238000012795 verification Methods 0.000 description 2
- AGNGYMCLFWQVGX-AGFFZDDWSA-N (e)-1-[(2s)-2-amino-2-carboxyethoxy]-2-diazonioethenolate Chemical compound OC(=O)[C@@H](N)CO\C([O-])=C\[N+]#N AGNGYMCLFWQVGX-AGFFZDDWSA-N 0.000 description 1
- WTOFYLAWDLQMBZ-UHFFFAOYSA-N 2-azaniumyl-3-thiophen-2-ylpropanoate Chemical compound OC(=O)C(N)CC1=CC=CS1 WTOFYLAWDLQMBZ-UHFFFAOYSA-N 0.000 description 1
- MJPCOTCPKZTNHX-UHFFFAOYSA-N 2-methyl-1,1-dinitroguanidine Chemical compound CN=C(N)N([N+]([O-])=O)[N+]([O-])=O MJPCOTCPKZTNHX-UHFFFAOYSA-N 0.000 description 1
- 108020005065 3' Flanking Region Proteins 0.000 description 1
- 108020005029 5' Flanking Region Proteins 0.000 description 1
- 244000063299 Bacillus subtilis Species 0.000 description 1
- 235000014469 Bacillus subtilis Nutrition 0.000 description 1
- 108020004705 Codon Proteins 0.000 description 1
- 241000186216 Corynebacterium Species 0.000 description 1
- 102100037579 D-3-phosphoglycerate dehydrogenase Human genes 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- 241000305071 Enterobacterales Species 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 102220624132 Minor histocompatibility antigen H13_S88G_mutation Human genes 0.000 description 1
- 102000004160 Phosphoric Monoester Hydrolases Human genes 0.000 description 1
- 108090000608 Phosphoric Monoester Hydrolases Proteins 0.000 description 1
- 108010019653 Pwo polymerase Proteins 0.000 description 1
- 108020004511 Recombinant DNA Proteins 0.000 description 1
- 108091081024 Start codon Proteins 0.000 description 1
- 101100378465 Streptomyces griseus pabAB gene Proteins 0.000 description 1
- 101100378467 Streptomyces venezuelae (strain ATCC 10712 / CBS 650.69 / DSM 40230 / JCM 4526 / NBRC 13096 / PD 04745) cmlB gene Proteins 0.000 description 1
- 108010006785 Taq Polymerase Proteins 0.000 description 1
- 241000319304 [Brevibacterium] flavum Species 0.000 description 1
- 238000007171 acid catalysis Methods 0.000 description 1
- 230000006154 adenylylation Effects 0.000 description 1
- 230000003281 allosteric effect Effects 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 235000019728 animal nutrition Nutrition 0.000 description 1
- 230000000340 anti-metabolite Effects 0.000 description 1
- 229940100197 antimetabolite Drugs 0.000 description 1
- 239000002256 antimetabolite Substances 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000001651 autotrophic effect Effects 0.000 description 1
- 229950011321 azaserine Drugs 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- UUQMNUMQCIQDMZ-UHFFFAOYSA-N betahistine Chemical compound CNCCC1=CC=CC=N1 UUQMNUMQCIQDMZ-UHFFFAOYSA-N 0.000 description 1
- 230000001851 biosynthetic effect Effects 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- RGWHQCVHVJXOKC-SHYZEUOFSA-J dCTP(4-) Chemical compound O=C1N=C(N)C=CN1[C@@H]1O[C@H](COP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O)[C@@H](O)C1 RGWHQCVHVJXOKC-SHYZEUOFSA-J 0.000 description 1
- HAAZLUGHYHWQIW-KVQBGUIXSA-N dGTP Chemical compound C1=NC=2C(=O)NC(N)=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 HAAZLUGHYHWQIW-KVQBGUIXSA-N 0.000 description 1
- NHVNXKFIZYSCEB-XLPZGREQSA-N dTTP Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)C1 NHVNXKFIZYSCEB-XLPZGREQSA-N 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 230000000593 degrading effect Effects 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 238000012262 fermentative production Methods 0.000 description 1
- 229940014144 folate Drugs 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 238000003209 gene knockout Methods 0.000 description 1
- 238000012239 gene modification Methods 0.000 description 1
- 230000005017 genetic modification Effects 0.000 description 1
- 235000013617 genetically modified food Nutrition 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 239000013028 medium composition Substances 0.000 description 1
- 238000010369 molecular cloning Methods 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 102000030592 phosphoserine aminotransferase Human genes 0.000 description 1
- 108010088694 phosphoserine aminotransferase Proteins 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 230000009145 protein modification Effects 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 230000002797 proteolythic effect Effects 0.000 description 1
- 239000011535 reaction buffer Substances 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000010187 selection method Methods 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 230000009469 supplementation Effects 0.000 description 1
- 238000010809 targeting technique Methods 0.000 description 1
- 238000009281 ultraviolet germicidal irradiation Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P13/00—Preparation of nitrogen-containing organic compounds
- C12P13/04—Alpha- or beta- amino acids
- C12P13/06—Alanine; Leucine; Isoleucine; Serine; Homoserine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C12N1/205—Bacterial isolates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/88—Lyases (4.)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/13—Brevibacterium
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/15—Corynebacterium
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Tropical Medicine & Parasitology (AREA)
- Virology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE102005049527A DE102005049527B4 (de) | 2005-10-17 | 2005-10-17 | Verfahren zur Herstellung von L-Serin, Gensequenz, Vektoren sowie Mikroorganismus |
| DE102005049527.3 | 2005-10-17 | ||
| PCT/DE2006/001756 WO2007045210A1 (de) | 2005-10-17 | 2006-10-09 | Verfahren zur herstellung von l-serin, gensequenz, vektoren sowie mikroorganismus |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI0617498A2 true BRPI0617498A2 (pt) | 2011-07-26 |
Family
ID=37775257
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0617498-1A BRPI0617498A2 (pt) | 2005-10-17 | 2006-10-09 | processo para a produÇço de l-serina, seqÜÊncia de gene, vetores e microorganismos |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20090181435A1 (enExample) |
| EP (1) | EP1937823A1 (enExample) |
| JP (1) | JP2009511076A (enExample) |
| KR (1) | KR20080049094A (enExample) |
| BR (1) | BRPI0617498A2 (enExample) |
| DE (1) | DE102005049527B4 (enExample) |
| WO (1) | WO2007045210A1 (enExample) |
| ZA (1) | ZA200804137B (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10793826B2 (en) * | 2015-01-27 | 2020-10-06 | Cysbio Aps | Genetically modified microorganisms having improved tolerance towards L-serine |
| AU2017357813B2 (en) | 2016-11-11 | 2024-07-25 | Boehringer Ingelheim Vetmedica Gmbh | Attenuating bacterial virulence by attenuating bacterial folate transport |
| KR102869970B1 (ko) * | 2023-06-23 | 2025-10-14 | 씨제이제일제당 (주) | 변이된 rbs 염기 서열을 포함하는 폴리뉴클리오티드, 상기 폴리뉴클레오티드를 포함하는 미생물, 및 이를 이용한 글리신 생산 방법 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5212273B1 (enExample) * | 1970-05-06 | 1977-04-06 | ||
| CA1097240A (en) | 1976-11-30 | 1981-03-10 | Kiyoshi Nakayama | Process for production of l-serine |
| JPS5372893A (en) * | 1976-12-08 | 1978-06-28 | Kyowa Hakko Kogyo Co Ltd | Preparation of l-serine by fermentation |
| DE3580463D1 (de) * | 1984-12-27 | 1990-12-13 | Ajinomoto Kk | Verfahren zur herstellung von l-serine. |
| JP3036912B2 (ja) * | 1991-09-02 | 2000-04-24 | 協和醗酵工業株式会社 | 遺伝子発現調節ｄｎａ |
| TW313589B (enExample) * | 1991-12-12 | 1997-08-21 | Wacker Chemie Gmbh | |
| JPH08107788A (ja) * | 1994-10-11 | 1996-04-30 | Mitsubishi Chem Corp | セリンヒドロキシメチルトランスフェラーゼをコードする遺伝子を含むｄｎａ断片 |
| JP4066543B2 (ja) * | 1998-01-12 | 2008-03-26 | 味の素株式会社 | 発酵法によるｌ−セリンの製造法 |
| JP3997631B2 (ja) * | 1998-01-12 | 2007-10-24 | 味の素株式会社 | 発酵法によるｌ−セリンの製造法 |
| JP2001112479A (ja) * | 1999-08-12 | 2001-04-24 | Ajinomoto Co Inc | コリネ型細菌で自律複製可能な新規プラスミド |
| DE19959329A1 (de) * | 1999-12-09 | 2001-06-13 | Degussa | Verfahren zur fermentativen Herstellung von L-Aminosäuren unter Verwendung coryneformer Bakterien |
| DE10154292A1 (de) * | 2001-11-05 | 2003-05-15 | Basf Ag | Gene die für Stoffwechselweg-Proteine codieren |
| DE10311399A1 (de) * | 2003-03-13 | 2004-09-23 | Forschungszentrum Jülich GmbH | Nukleotidsequenzen coryneformer Bakterien codierend für am L-Serinstoffwechsel beteiligte Proteine sowie Verfahren zur mikrobiellen Herstellung von L-Serin |
-
2005
- 2005-10-17 DE DE102005049527A patent/DE102005049527B4/de not_active Expired - Lifetime
-
2006
- 2006-10-09 BR BRPI0617498-1A patent/BRPI0617498A2/pt not_active IP Right Cessation
- 2006-10-09 EP EP06805376A patent/EP1937823A1/de not_active Withdrawn
- 2006-10-09 JP JP2008535878A patent/JP2009511076A/ja active Pending
- 2006-10-09 KR KR1020087008076A patent/KR20080049094A/ko not_active Withdrawn
- 2006-10-09 US US12/083,662 patent/US20090181435A1/en not_active Abandoned
- 2006-10-09 WO PCT/DE2006/001756 patent/WO2007045210A1/de not_active Ceased
-
2008
- 2008-05-14 ZA ZA200804137A patent/ZA200804137B/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2007045210A1 (de) | 2007-04-26 |
| DE102005049527B4 (de) | 2013-05-08 |
| US20090181435A1 (en) | 2009-07-16 |
| ZA200804137B (en) | 2009-10-28 |
| DE102005049527A1 (de) | 2007-04-19 |
| JP2009511076A (ja) | 2009-03-19 |
| KR20080049094A (ko) | 2008-06-03 |
| EP1937823A1 (de) | 2008-07-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR20240012383A (ko) | 아미노산 엑스포터의 불활성화에 의해 구아니디노 아세트산 (gaa) 제조를 위한 개선된 생명공학 방법 | |
| DK2855662T3 (en) | RECOMBINANT MICROORGANISMS AND APPLICATIONS THEREOF | |
| KR102074841B1 (ko) | 피드백-내성 알파-이소프로필말레이트 신타제 | |
| CN107299114B (zh) | 一种高效的酵母菌染色体融合方法 | |
| ES2930286T3 (es) | Microorganismos y métodos para producir oligosacáridos sialilados y que contienen N-acetilglucosamina | |
| KR20250057148A (ko) | 푸코실트랜스퍼라제 및 푸코실화된 올리고사카라이드의 제조에서 그의 용도 | |
| Mojumdar et al. | Characterization of the tetracycline resistance gene of plasmid pT181 of Staphylococcus aureus | |
| AU2016364229A1 (en) | Means and methods for preparing engineered proteins by genetic code expansion in insect cells | |
| KR20190138274A (ko) | 클로스트리디움 박테리아의 변형을 위한 최적화된 유전 툴 | |
| KR20120094137A (ko) | 카다베린의 생산을 위한 방법 및 재조합 미생물 | |
| JP2004507217A (ja) | リステリア菌ゲノム、ポリペプチドおよびその使用 | |
| KR20140101890A (ko) | 3-히드록시이소부티르산의 생명공학적 제조 | |
| BR102018011843A2 (pt) | Método para produção de produtos químicos finos com o uso de um corynebacterium que secreta a-1,6-glicosidases modificadas | |
| AU2018368610B2 (en) | Production of a flavour compound in a host cell | |
| CN109971778B (zh) | 一种在盐单胞菌中快速基因编辑的载体组合及其应用 | |
| CN114836459B (zh) | 一种胞嘧啶碱基编辑系统及其应用 | |
| BRPI0617498A2 (pt) | processo para a produÇço de l-serina, seqÜÊncia de gene, vetores e microorganismos | |
| KR20210118826A (ko) | 유전자 변형된 클로스트리디움 박테리아, 그의 제조 및 용도 | |
| TW200533749A (en) | Pgro expression units | |
| KR102282778B1 (ko) | 재조합 미생물 및 이의 사용 방법 | |
| CN109504748A (zh) | 一种提高RAA技术在SNPs检测中特异性的方法 | |
| KR20220093189A (ko) | 세포에서 생물학적 설계를 가속화하기 위한 모듈식 무세포 단백질 발현 벡터 | |
| KR20220012324A (ko) | 박테리아의 변형을 위해 최적화된 유전자 도구 | |
| US11236401B2 (en) | Sensors for detection and quantification of microbiological protein secretion | |
| US8790900B2 (en) | Microorganisms having enhanced sucrose mutase activity |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 8A ANUIDADE. |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2275 DE 12/08/2014. |
|
| B15G | Petition not considered as such [chapter 15.7 patent gazette] |
Free format text: A PETICAO INPI/RJ NO 020130073870 DE 03/09/2013, NAO DEVE SER CONHECIDA, EM VIRTUDE DO DISPOSTO NO ARTIGO 219 INCISO II DA LPI NO 9.279/96, UMA VEZ QUE NAO HA FUNDAMENTACAO LEGAL. |